MRI study of kidney disease in ARPKD
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses MRI scans to track kidney disease progression in children and adults with ARPKD. It aims to better understand how the disease changes over time, which could help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 6 years old.
- You have a confirmed diagnosis of ARPKD (a rare genetic kidney disease that starts in childhood).
- You can lie still inside an MRI machine for about 30 minutes.
- Your kidney function (eGFR) is above 30, based on a blood test done in the last year.
- You have not had a kidney or other solid organ transplant.
- You do not have any metal implants or other reasons that make an MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at medical records, imaging, and genetic testing for people with autosomal recessive polycystic kidney disease (ARPKD). It may help researchers better understand the condition and how it affects the liver and kidneys.
This study looks at how the body’s “Nrf2 response” works in people with autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand disease biology and future treatments by comparing kidney-related signals in ADPKD patients and healthy volunteers.
This study uses MRI scans to develop better imaging tools for kidney disease and to test them in people with kidney problems. It may help improve how doctors measure kidney health in the future.
This study uses a special MRI scan to look at the kidneys in people with different kinds of kidney disease, including acute kidney injury, chronic kidney disease, vasculitis, and after a kidney transplant. The goal is to better understand these conditions.
This observational study follows people early in autosomal dominant polycystic kidney disease (ADPKD) and also some healthy volunteers to learn how the kidneys work over time. It may help researchers understand early changes, which could guide future treatments.
This study uses a special MRI technique to look at the kidneys in people with chronic kidney disease. It helps doctors see how the disease is affecting your kidneys and may guide better treatment.
Hear when a new Autosomal Recessive Polycystic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.